Abstract
Moyamoya disease (MMD) is a rare disease, with typical characteristics including progressive stenosis or occlusion of the bilateral internal carotid artery and accompanying basal collateral formation. Although MMD only accounts for a small portion of stroke in the elderly, it is the most common cause of pediatric stroke in East Asia. East Asian regional predilection and female predominance are well-known epidemiologic features, and the age of onset follows a bimodal distribution. The affected blood vessel shows intimal hyperplasia with shrinkage of the outer diameter. Owing to stenosis or occlusion, cerebral perfusion decreases, resulting in ischemic symptoms that include transient ischemic attack or cerebral infarction. In these cases, cerebral revascularization surgery is effective to prevent stroke reoccurrence and neurological deterioration. The fragility of fine collateral vascular networks is another problem. These are prone to rupture leading to intraventricular or intracerebral hemorrhage. Cerebral revascularization surgery can reduce the extent of fragile collaterals by augmenting cerebral blood flow. One study reported that extensive bilateral direct bypass surgery could prevent further hemorrhage by decreasing blood flow through fragile collaterals. Another reported option to prevent further hemorrhage is endovascular obliteration of the aneurysm (or pseudoaneurysm) at the site of hemorrhage.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kim T, Lee H, Bang JS, et al. Epidemiology of moyamoya disease in Korea: based on national health insurance service data. J Korean Neurosurg Soc. 2015;57:390–5.
Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. 2008;39:42–7.
Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008;79:900–4.
Ikeda H, Sasaki T, Yoshimoto T, et al. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999;64:533–7.
Liu W, Morito D, Takashima S, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011;6:e22542.
Kim EH, Yum MS, Ra YS, et al. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg. 2016;124:1221–7.
Cecchi AC, Guo D, Ren Z, et al. RNF213 rare variants in an ethnically diverse population with Moyamoya disease. Stroke. 2014;45:3200–7.
Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997;99(Suppl 2):S238–40.
Cho WS, Kim JE, Paeng JC, et al. Can combined bypass surgery at middle cerebral artery territory save anterior cerebral artery territory in adult moyamoya disease? Neurosurgery. 2017;80:431–8.
Kim T, Oh CW, Kwon OK, et al. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia. J Neurosurg. 2016;124:1788–93.
Kim H, Jang DK, Han YM et al. Direct bypass versus indirect bypass in adult moyamoya angiopathy with symptoms or hemodynamic instability: A meta-analysis of comparative studies. World Neurosurg. 2016;94:273–84.
Kim T, Oh CW, Bang JS, et al. Moyamoya disease: treatment and outcomes. J Stroke. 2016;18:21–30.
Ahn JH, Wang KC, Phi JH, et al. Hemorrhagic moyamoya disease in children: clinical features and surgical outcome. Childs Nerv Syst. 2012;28:237–45.
Miyamoto S, Yoshimoto T, Hashimoto N, et al. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke. 2014;45:1415–21.
Kim SH, Kwon OK, Jung CK, et al. Endovascular treatment of ruptured aneurysms or pseudoaneurysms on the collateral vessels in patients with moyamoya disease. Neurosurgery. 2009;65:1000–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Kim, T., Oh, C.W. (2017). Moyamoya Disease. In: Lee, SH. (eds) Stroke Revisited: Diagnosis and Treatment of Ischemic Stroke. Stroke Revisited. Springer, Singapore. https://doi.org/10.1007/978-981-10-1424-6_20
Download citation
DOI: https://doi.org/10.1007/978-981-10-1424-6_20
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-1423-9
Online ISBN: 978-981-10-1424-6
eBook Packages: MedicineMedicine (R0)